Advertisement EY mid banner
Advertisement: Cambridge Network
Mid banner advertisement: BDO
RealVNC mid-banner general
RealVNC mid banner careers
Barr Ellison Solicitors – commercial property
Advertisement: Bradfield Centre mid
Advertisement: RSM
ARM Innovation Hub
Advertisement: Mogrify
Advertisement Cambridge China Centre
15 February, 2006 - 16:18 By Staff Reporter

Smart awarded DTI Knowledge Transfer Partnership with the University of Bath

Smart Holograms’ programme for the development of novel glucose sensors for diabetics was given a boost this week with the award of a grant from the Knowledge Transfer Partnership (KTP) scheme to fund a KTP Associate.

The objective of the grant, awarded to Smart and the University of Bath, is the research, development and implementation of novel glucose receptors for use in Sensor Holograms, the Company’s pioneering diagnostic technology.

Dr John Pritchard, chief technology officer at Smart Holograms, said: “Tony James at Bath University is the leading expert in his field. His experience will be of invaluable to the development of our business and technology.”

Dr Tony James, Senior Lecturer in Organic Chemistry and Royal Society Research Fellow, at Bath University said: “My group have been working in this area for a number of years. Our collaboration with Smart, through a KTP associate, will be of enormous benefit to our ongoing research at the University of Bath.”

KTP Programme Manager at the University of Bath, Richard Battams, said: “Knowledge Transfer Partnerships deliver huge benefits for the Company, University and Graduate employed. It is especially exciting for me to be involved in this project, which has the potential to benefit the large number of people that have to live with diabetes.”

Smart Holograms is developing glucose sensors for minimally-invasive, continuous monitoring. The Sensor Hologram approach that Smart is pioneering is not only distinct from but has many clear advantages over competing technologies, including power-free function and low-cost, simple manufacture.

Furthermore, they are unaffected by environmental conditions, are made from the same materials as found in contact lenses and tissue implants and use synthetic receptors allowing them to be sterilised by conventional means and used in-vivo.

 

Add new comment

Newsletter Subscription

Stay informed of the latest news and features